X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-01-26 | JEWL | Adamas One Corp. | Grdina John | Pres, CEO | P - Purchase | $2.51 | +20,000 | 6,759,458 | 0% | +$50,156 | ||||||
| M | 2023-01-24 | CCO | Clear Channel Outdoor Holdings, Inc. | Ares Management LLC | 10% | P - Purchase | $1.60 | +1,596,000 | 54,205,626 | +3% | +$2,553,310 | |||||
| M | 2023-01-24 | CCO | Clear Channel Outdoor Holdings, Inc. | Ares Management LLC | 10% | P - Purchase | $1.60 | +1,596,000 | 54,205,626 | +3% | +$2,553,310 | |||||
| M | 2023-01-24 | TTNP | Titan Pharmaceuticals Inc | Lazar David E. | CEO, 10% | P - Purchase | $0.98 | +57,500 | 3,747,968 | +2% | +$56,287 | |||||
2023-01-10 | DHY | Credit Suisse High Yield Bond Fund | Flannery Thomas J. | Chief Investment Officer | P - Purchase | $1.84 | +45,000 | 195,000 | +30% | +$82,793 | ||||||
| D | 2023-01-25 | APLD | Applied Blockchain, Inc. | Cummins Wes | CEO; COB, 10% | P - Purchase | $2.48 | +25,000 | 22,982,754 | 0% | +$62,000 | |||||
2023-01-23 | EIGR | Eiger Biopharmaceuticals, Inc. | Dietz Thomas John | Dir | P - Purchase | $1.43 | +50,000 | 71,000 | +238% | +$71,580 | ||||||
2023-01-23 | NGM | Ngm Biopharmaceuticals Inc | Column Group L P | Dir, 10% | P - Purchase | $5.00 | +9,900 | 21,536,510 | 0% | +$49,494 | ||||||
2023-01-23 | NGM | Ngm Biopharmaceuticals Inc | Column Group L P | Dir, 10% | P - Purchase | $5.00 | +9,900 | 21,536,510 | 0% | +$49,494 | ||||||
2023-01-23 | NGM | Ngm Biopharmaceuticals Inc | Column Group L P | Dir, 10% | P - Purchase | $5.00 | +9,900 | 21,536,510 | 0% | +$49,494 | ||||||
2023-01-23 | NGM | Ngm Biopharmaceuticals Inc | Goeddel David V | Dir, 10% | P - Purchase | $5.00 | +9,900 | 21,797,510 | 0% | +$49,494 | ||||||
2023-01-23 | JEWL | Adamas One Corp. | Grdina John | Pres, CEO | P - Purchase | $2.67 | +40,000 | 6,739,458 | +1% | +$106,780 | ||||||
| D | 2023-01-24 | APLD | Applied Blockchain, Inc. | Cummins Wes | CEO; COB, 10% | P - Purchase | $2.45 | +25,000 | 22,957,754 | 0% | +$61,250 | |||||
| M | 2023-01-20 | CCO | Clear Channel Outdoor Holdings, Inc. | Ares Management LLC | 10% | P - Purchase | $1.57 | +1,230,000 | 53,631,580 | +2% | +$1,927,006 | |||||
| M | 2023-01-20 | CCO | Clear Channel Outdoor Holdings, Inc. | Ares Management LLC | 10% | P - Purchase | $1.57 | +1,230,000 | 53,631,580 | +2% | +$1,927,006 | |||||
2023-01-23 | GIM | Templeton Global Income Fund | Saba Capital Management, L.P. | 10% | P - Purchase | $4.43 | +20,000 | 35,955,747 | 0% | +$88,600 | ||||||
2023-01-24 | CMPX | Compass Therapeutics, Inc. | Schuetz Thomas J. | CEO | P - Purchase | $4.19 | +20,000 | 5,451,873 | 0% | +$83,800 | ||||||
| D | 2023-01-23 | APLD | Applied Blockchain, Inc. | Cummins Wes | CEO; COB, 10% | P - Purchase | $2.33 | +25,000 | 22,932,754 | 0% | +$58,250 | |||||
| D | 2023-01-20 | GUER | Guerrilla Rf, Inc. | Barkal Susan Berish | Dir | P - Purchase | $1.30 | +40,000 | 40,000 | New | +$52,000 | |||||
2023-01-19 | TNYA | Tenaya Therapeutics, Inc. | Column Group III Gp, LP | 10% | P - Purchase | $2.50 | +69,739 | 19,270,564 | 0% | +$174,201 | ||||||
| M | 2023-01-19 | NGM | Ngm Biopharmaceuticals Inc | Column Group L P | Dir, 10% | P - Purchase | $5.00 | +38,139 | 21,526,610 | 0% | +$190,603 | |||||
| M | 2023-01-19 | NGM | Ngm Biopharmaceuticals Inc | Column Group L P | Dir, 10% | P - Purchase | $5.00 | +38,139 | 21,526,610 | 0% | +$190,603 | |||||
2023-01-19 | TNYA | Tenaya Therapeutics, Inc. | Goeddel David V | Dir, 10% | P - Purchase | $2.50 | +69,739 | 19,270,564 | 0% | +$174,201 | ||||||
| M | 2023-01-19 | NGM | Ngm Biopharmaceuticals Inc | Column Group L P | Dir, 10% | P - Purchase | $5.00 | +38,139 | 21,526,610 | 0% | +$190,603 | |||||
| D | 2022-12-30 | AAME | Atlantic American Corp | Robinson Harriett J | Trustee under Rule 16a-8, 10% | P - Purchase | $3.00 | +300,000 | 15,217,583 | +2% | +$900,000 | |||||
| M | 2023-01-19 | NGM | Ngm Biopharmaceuticals Inc | Goeddel David V | Dir, 10% | P - Purchase | $5.00 | +38,139 | 21,787,610 | 0% | +$190,603 | |||||
2023-01-20 | XOS | Xos, Inc. | Sordoni Giordano | COO | P - Purchase | $0.99 | +73,513 | 23,916,681 | 0% | +$72,778 | ||||||
| D | 2023-01-20 | APLD | Applied Blockchain, Inc. | Cummins Wes | CEO; COB, 10% | P - Purchase | $2.41 | +20,000 | 22,907,754 | 0% | +$48,200 | |||||
| M | 2023-01-18 | CCO | Clear Channel Outdoor Holdings, Inc. | Ares Management LLC | 10% | P - Purchase | $1.36 | +1,000,000 | 52,401,580 | +2% | +$1,356,920 | |||||
| M | 2023-01-18 | CCO | Clear Channel Outdoor Holdings, Inc. | Ares Management LLC | 10% | P - Purchase | $1.36 | +1,000,000 | 52,401,580 | +2% | +$1,356,920 | |||||
| D | 2023-01-19 | APLD | Applied Blockchain, Inc. | Cummins Wes | CEO; COB, 10% | P - Purchase | $2.40 | +25,000 | 22,887,754 | 0% | +$60,000 | |||||
| M | 2023-01-17 | XOS | Xos, Inc. | Sordoni Giordano | COO | P - Purchase | $1.02 | +168,268 | 23,843,168 | +1% | +$171,894 | |||||
2023-01-17 | CCO | Clear Channel Outdoor Holdings, Inc. | Ares Management LLC | 10% | P - Purchase | $1.36 | +400,000 | 51,401,580 | +1% | +$544,120 | ||||||
2023-01-17 | CCO | Clear Channel Outdoor Holdings, Inc. | Ares Management LLC | 10% | P - Purchase | $1.36 | +400,000 | 51,401,580 | +1% | +$544,120 | ||||||
| M | 2023-01-11 | LTBR | Lightbridge Corp | Ak Jensen Investment Management Ltd | 10% | P - Purchase | $4.58 | +75,347 | 2,424,132 | +3% | +$345,433 | |||||
| M | 2023-01-17 | TNYA | Tenaya Therapeutics, Inc. | Column Group III Gp, LP | 10% | P - Purchase | $2.51 | +185,151 | 19,200,825 | +1% | +$464,827 | |||||
2023-01-18 | DYNR | Dynaresource Inc | Rose Matthew K | Dir, 10% | P - Purchase | $2.30 | +27,100 | 2,935,840 | +1% | +$62,330 | ||||||
| M | 2023-01-17 | TNYA | Tenaya Therapeutics, Inc. | Goeddel David V | Dir, 10% | P - Purchase | $2.51 | +185,151 | 19,200,825 | +1% | +$464,827 | |||||
| DM | 2022-11-01 | ENZ | Enzo Biochem Inc | Wolf James G. | 10% | P - Purchase | $2.15 | +23,000 | 4,233,500 | +1% | +$49,400 | |||||
| D | 2023-01-18 | APLD | Applied Blockchain, Inc. | Cummins Wes | CEO; COB, 10% | P - Purchase | $2.35 | +50,000 | 22,862,754 | 0% | +$117,500 | |||||
| DM | 2022-11-01 | ENZ | Healthtech Solutions, Inc./Ut | Wolf James G. | 10% | P - Purchase | $2.15 | +23,000 | 4,233,500 | +1% | +$49,400 | |||||
2023-01-17 | MYO | Myomo, Inc. | Henry David A | CFO | P - Purchase | $0.33 | +76,923 | 163,527 | +89% | +$25,000 | ||||||
2023-01-17 | MYO | Myomo, Inc. | Gudonis Paul R | CEO | P - Purchase | $0.33 | +307,692 | 483,345 | +175% | +$100,000 | ||||||
| M | 2023-01-13 | XOS | Xos, Inc. | Mattson George N | Dir | P - Purchase | $0.98 | +128,666 | 4,819,247 | +3% | +$126,379 | |||||
| D | 2023-01-17 | APLD | Applied Blockchain, Inc. | Cummins Wes | CEO; COB, 10% | P - Purchase | $2.25 | +50,000 | 22,812,754 | 0% | +$112,500 | |||||
2023-01-13 | CCO | Clear Channel Outdoor Holdings, Inc. | Ares Management LLC | 10% | P - Purchase | $1.39 | +330,000 | 51,001,580 | +1% | +$459,921 | ||||||
2023-01-13 | CCO | Clear Channel Outdoor Holdings, Inc. | Ares Management LLC | 10% | P - Purchase | $1.39 | +330,000 | 51,001,580 | +1% | +$459,921 | ||||||
2023-01-12 | NGM | Ngm Biopharmaceuticals Inc | Column Group L P | Dir, 10% | P - Purchase | $4.95 | +5,378 | 21,488,471 | 0% | +$26,603 | ||||||
2023-01-13 | ACHR | Archer Aviation Inc. | Spellacy Michael | Dir | P - Purchase | $2.60 | +23,116 | 146,505 | +19% | +$59,998 | ||||||
2023-01-12 | NGM | Ngm Biopharmaceuticals Inc | Column Group L P | Dir, 10% | P - Purchase | $4.95 | +5,378 | 21,488,471 | 0% | +$26,603 | ||||||
2023-01-12 | NGM | Ngm Biopharmaceuticals Inc | Column Group L P | Dir, 10% | P - Purchase | $4.95 | +5,378 | 21,488,471 | 0% | +$26,603 | ||||||
2023-01-13 | ACHR | Archer Aviation Inc. | Mesler Mark | CFO | P - Purchase | $2.63 | +20,000 | 20,000 | New | +$52,612 | ||||||
2023-01-12 | NGM | Ngm Biopharmaceuticals Inc | Goeddel David V | Dir, 10% | P - Purchase | $4.95 | +5,378 | 21,749,471 | 0% | +$26,603 | ||||||
2023-01-12 | ACHR | Archer Aviation Inc. | Goldstein Adam D | CEO, 10% | P - Purchase | $2.54 | +39,526 | 139,526 | +40% | +$100,238 | ||||||
2023-01-12 | ACHR | Archer Aviation Inc. | Diaz Fred M | Dir | P - Purchase | $2.59 | +19,322 | 52,711 | +58% | +$49,998 | ||||||
| D | 2023-01-13 | APLD | Applied Blockchain, Inc. | Cummins Wes | CEO; COB, 10% | P - Purchase | $2.17 | +75,000 | 22,762,754 | 0% | +$162,750 | |||||
2023-01-11 | GIM | Templeton Global Income Fund | Saba Capital Management, L.P. | 10% | P - Purchase | $4.36 | +20,000 | 35,935,747 | 0% | +$87,200 | ||||||
2022-12-22 | ALMU | Aeluma, Inc. | Tompkins Mark N. | 10% | P - Purchase | $3.00 | +83,333 | 2,715,833 | +3% | +$249,999 | ||||||
| M | 2023-01-03 | ETST | Earth Science Tech, Inc. | Saumat Giorgio R. | Dir, 10% | P - Purchase | $0.01 | +6,010,000 | 81,916,478 | +8% | +$30,310 | |||||
| D | 2023-01-12 | APLD | Applied Blockchain, Inc. | Cummins Wes | CEO; COB, 10% | P - Purchase | $2.17 | +50,000 | 22,687,754 | 0% | +$108,500 | |||||
2023-01-03 | GGROU | Golden Growers Cooperative | Harless Mark Leon | COB | P - Purchase | $4.50 | +10,000 | 58,000 | +21% | +$45,000 | ||||||
| M | 2023-01-10 | NGM | Ngm Biopharmaceuticals Inc | Column Group L P | Dir, 10% | P - Purchase | $4.79 | +309,070 | 21,483,093 | +1% | +$1,479,359 | |||||
| M | 2023-01-10 | NGM | Ngm Biopharmaceuticals Inc | Column Group L P | Dir, 10% | P - Purchase | $4.79 | +309,070 | 21,483,093 | +1% | +$1,479,359 | |||||
| M | 2023-01-10 | NGM | Ngm Biopharmaceuticals Inc | Column Group L P | Dir, 10% | P - Purchase | $4.79 | +309,070 | 21,483,093 | +1% | +$1,479,359 | |||||
| M | 2023-01-10 | NGM | Ngm Biopharmaceuticals Inc | Goeddel David V | Dir, 10% | P - Purchase | $4.79 | +309,070 | 21,744,093 | +1% | +$1,479,359 | |||||
| M | 2023-01-09 | XOS | Xos, Inc. | Mattson George N | Dir | P - Purchase | $0.97 | +185,343 | 4,690,581 | +4% | +$180,343 | |||||
| M | 2022-12-14 | UPXI | Upexi, Inc. | Marshall Allan | CEO, 10% | P - Purchase | $3.69 | +17,303 | 2,575,081 | +1% | +$63,909 | |||||
| D | 2022-11-30 | TCBP | Tc Biopharm (Holdings) Plc | Randall Diana Elizabeth | 10% | P - Purchase | $5.00 | +70,000 | 138,842 | +102% | +$350,000 | |||||
| AD | 2022-11-30 | TCBP | Tc Biopharm (Holdings) Plc | Randall Mark Edward | 10% | P - Purchase | $5.00 | +70,000 | 146,786 | +91% | +$350,000 | |||||
| AD | 2022-11-30 | TCBP | Tc Biopharm (Holdings) Plc | Randall Kenneth Edward | 10% | P - Purchase | $5.00 | +70,000 | 138,842 | +102% | +$350,000 | |||||
| D | 2022-11-30 | TCBP | Tc Biopharm (Holdings) Plc | Randall Mark Edward | 10% | P - Purchase | $5.00 | +70,000 | 392,915 | +22% | +$350,000 | |||||
| D | 2022-11-30 | TCBP | Tc Biopharm (Holdings) Plc | Randall Kenneth Edward | 10% | P - Purchase | $5.00 | +70,000 | 384,971 | +22% | +$350,000 | |||||
| D | 2022-11-30 | TCBP | Tc Biopharm (Holdings) Plc | Renaissance Capital Partners Ltd | 10% | P - Purchase | $5.00 | +70,000 | 136,834 | +105% | +$350,000 | |||||
2023-01-06 | GEG | Great Elm Group, Inc. | Reese Jason W. | Dir, 10% | P - Purchase | $2.17 | +460,900 | 11,509,161 | +4% | +$1,000,153 | ||||||
2023-01-06 | HOWL | Werewolf Therapeutics, Inc. | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $2.21 | +1,853,000 | 6,144,881 | +43% | +$4,095,130 | ||||||
2023-01-10 | ERAS | Erasca, Inc. | Lim Jonathan E | COB, CEO, 10% | P - Purchase | $3.86 | +60,000 | 32,155,582 | 0% | +$231,420 | ||||||
2023-01-09 | BTMD | Biote Corp. | Kamdar Samar Jagat | CFO | P - Purchase | $3.00 | +13,000 | 13,000 | New | +$39,000 | ||||||
2023-01-09 | BTMD | Biote Corp. | Morris Debra L | Dir | P - Purchase | $3.00 | +30,000 | 30,000 | New | +$90,000 | ||||||
2023-01-09 | BTMD | Biote Corp. | Cone Stephen Mark | Dir | P - Purchase | $3.00 | +83,350 | 106,823 | +355% | +$250,050 | ||||||
2023-01-09 | BTMD | Biote Corp. | Heyer Andrew R | Dir | P - Purchase | $3.00 | +200,000 | 2,217,156 | +10% | +$600,000 | ||||||
| M | 2023-01-05 | XOS | Xos, Inc. | Semler Dakota | CEO | P - Purchase | $0.88 | +250,189 | 57,701,252 | 0% | +$220,278 | |||||
| AM | 2022-09-14 | LDI | Loandepot, Inc. | Hsieh Anthony Li | Exec COB, 10% | P - Purchase | $1.60 | +102,637 | 3,891,349 | +3% | +$164,219 | |||||
| A | 2022-09-13 | LDI | Loandepot, Inc. | Hsieh Anthony Li | Exec COB, 10% | P - Purchase | $1.60 | +28,508 | 3,788,712 | +1% | +$45,613 | |||||
| M | 2023-01-05 | SEAC | Seachange International Inc | Singer Karen | 10% | P - Purchase | $0.49 | +178,115 | 8,819,311 | +2% | +$87,103 | |||||
| D | 2023-01-04 | CMRA | Comera Life Sciences Holdings, Inc. | Cherington Charles | 10% | P - Purchase | $1.23 | +743,243 | 4,434,410 | +20% | +$914,189 | |||||
| D | 2023-01-04 | CMRA | Comera Life Sciences Holdings, Inc. | Soane David | 10% | P - Purchase | $1.23 | +202,701 | 678,515 | +43% | +$249,322 | |||||
2022-11-21 | BDSX | Biodesix Inc | Kennedy Lawrence T. Jr | 10% | P - Purchase | $1.15 | +10,869,565 | 14,827,404 | +275% | +$12,500,000 | ||||||
2023-01-03 | CAMP | Calamp Corp. | Cummins Wes | Dir | P - Purchase | $4.43 | +20,000 | 3,421,972 | +1% | +$88,610 | ||||||
| M | 2022-12-22 | EPIX | Essa Pharma Inc. | Parkinson David Ross | CEO | P - Purchase | $2.42 | +24,434 | 56,542 | +76% | +$59,041 | |||||
| M | 2023-01-03 | XOS | Xos, Inc. | Mattson George N | Dir | P - Purchase | $0.58 | +184,597 | 4,491,350 | +4% | +$106,990 | |||||
2023-01-03 | PLX | Protalix Biotherapeutics, Inc. | Schwartz Aharon | Dir | P - Purchase | $1.42 | +110,000 | 174,000 | +172% | +$155,815 | ||||||
2023-01-03 | IMRA | Imara Inc. | Ra Capital Management, L.P. | 10% | P - Purchase | $4.00 | +629,297 | 3,880,021 | +19% | +$2,516,055 | ||||||
2023-01-03 | RDFN | Redfin Corp | Slavet James | Dir | P - Purchase | $4.49 | +6,667 | 229,214 | +3% | +$29,962 | ||||||
| M | 2023-01-03 | AUGG | Augusta Gold Corp. | Augusta Investments Inc. | Dir, 10% | P - Purchase | $1.43 | +20,000 | 22,069,388 | 0% | +$28,556 | |||||
2022-12-12 | GLXZ | Galaxy Gaming, Inc. | Hagerty Harry C III | CFO | P - Purchase | $2.50 | +10,000 | 890,500 | +1% | +$25,000 | ||||||
| DM | 2022-12-14 | PKTX | Protokinetix, Inc. | Smith Clarence Edward | Pres, CEO, 10% | P - Purchase | $0.02 | +2,187,489 | 57,387,092 | +4% | +$46,868 | |||||
| D | 2022-12-30 | GUER | Guerrilla Rf, Inc. | Berg John Alen | CFO | P - Purchase | $1.30 | +20,000 | 163,581 | +14% | +$26,000 | |||||
2022-12-30 | TZOO | Travelzoo | Bartel Ralph | 10% | P - Purchase | $4.40 | +3,410,000 | 7,906,603 | +76% | +$15,004,000 | ||||||
2022-12-30 | TZOO | Travelzoo | Azzurro Capital Inc | 10% | P - Purchase | $4.40 | +3,410,000 | 7,663,858 | +80% | +$15,004,000 | ||||||
2022-12-30 | LIXT | Lixte Biotechnology Holdings, Inc. | Van Der Baan Bastiaan Jeroen | Dir | P - Purchase | $4.90 | +10,000 | 10,000 | New | +$49,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |